Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by GLUL belongs to the glutamine synthetase family. Additionally we are shipping Glutamate-Ammonia Ligase Proteins (40) and Glutamate-Ammonia Ligase Kits (22) and many more products for this protein.
Showing 10 out of 81 products:
Human Monoclonal GLUL Primary Antibody for WB - ABIN393316
Martins-de-Souza, Maccarrone, Wobrock, Zerr, Gormanns, Reckow, Falkai, Schmitt, Turck: Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia. in Journal of psychiatric research 2010
Show all 5 references for ABIN393316
Human Monoclonal GLUL Primary Antibody for FACS, IF - ABIN2453072
Shajahan-Haq, Cook, Schwartz-Roberts, Eltayeb, Demas, Warri, Facey, Hilakivi-Clarke, Clarke: MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer. in Molecular cancer 2014
Human Polyclonal GLUL Primary Antibody for IHC (p), WB - ABIN390879
Di Tommaso, Destro, Seok, Balladore, Terracciano, Sangiovanni, Iavarone, Colombo, Jang, Yu, Jin, Morenghi, Park, Roncalli: The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma. in Journal of hepatology 2009
Human Monoclonal GLUL Primary Antibody for ELISA, WB - ABIN561060
Herbert, Kuiperij, Verbeek: Optimisation of the quantification of glutamine synthetase and myelin basic protein in cerebrospinal fluid by a combined acidification and neutralisation protocol. in Journal of immunological methods 2012
Glutamine synthetase expression was highest in gluteus and semimembranous muscles and much lower in diaphragm and heart muscles.
This study demonstrated that Influence of glutamine synthetase gene polymorphisms on the development of hyperammonemia during valproic acid-based therapy.
GS is acetylated at lysines 11 and 14, yielding a degron that is necessary and sufficient for binding and ubiquitylation by CRL4(CRBN (show CRBN Antibodies)) and degradation by the proteasome.
Studied molecular mechanisms of glutamine synthetase mutations that lead to clinically relevant pathologies.
GLUL rs10911021 is associated prospectively with adjudicated cardiovascular composite end points among overweight/obese individuals with type 2 diabetes.
Data show that glutamine synthetase (GS) produces glutamine (show GFPT1 Antibodies) (Gln) from tricarboxylic acid (TCA)-cycle-derived carbons.
Data indicate that the triple stain of reticulin, glypican-3 (show GPC3 Antibodies), and glutamine (show GFPT1 Antibodies) synthetae is useful in the differentiation of hepatocellular carcinoma, hepatic adenoma, and focal nodular hyperplasia.
Results highlight the diagnostic errors that can be caused by variant patterns of staining with glutamine synthetase and serum amyloid-associated protein in inflammatory hepatocellular adenoma and focal nodular hyperplasia.
High Glutamine synthetase expression is associated with epilepsy in newly diagnosed glioblastoma multiforme.
Glutamine synthetase expression is increased in regenerating hepatocytes and in early hepatocyte progenitor cells prior to morphological evidence of hepatocellular differentiation.
through a 3-stage genome-wide association study in 4188 type 2 diabetic patients, identified a novel susceptibility locus for coronary heart disease in the region of the GLUL gene
This study concludes that hepatic expression of alanine transaminase and glutathione synthetase (GS (show GSS Antibodies)) are reduced in aged cows, and administration of 17beta-estradiol increases plasma estradiol and hepatic GS.
Data show that glutamine synthetase (GS)protein was preferentially expressed in hepatocytes adjacent to oxygen-supplying capillaries and in previously CPS-positive hepatocytes.
Results indicate that astrocyte glutamine synthase may be the predominant contributor to the pathogenic mechanisms of D-gal (show GAL Antibodies)-induced brain aging in mice.
Hepatic deletion of GS triggered systemic hyperammonemia, which was associated with cerebral oxidative stress as indicated by increased levels of oxidized RNA and enhanced protein Tyr (show TYR Antibodies) nitration.
modulation of intracellular glutamine (show GFPT1 Antibodies) levels by GS expression represents an endogenous mechanism through which mature adipocytes control the inflammatory response
GABABR2 (show GABBR2 Antibodies) has a role as a regulator of glutamine synthetase stability
the capacity for ammonia disposal correlated inversely with the expression of glutamine synthetase in muscle
Glutamine synthetase in astrocytes from entorhinal cortex of the triple transgenic animal model of Alzheimer's disease is not affected by pathological disease progression.
Renal glutamine synthetase is expressed in type A intercalated cells, non-A, non-B intercalated cells, and distal convoluted tubule cells, but not in principal cells, type B intercalated cells, or connecting segment cells.
Methionine sulfoximine target glutamine synthetase is required for the early steps of the cytokine response to endotoxins, and that its pharmacological inhibition may be exploited to treat inflammation.
BDNF (show BDNF Antibodies) can up-regulate GLAST (show SLC1A3 Antibodies) and GS and increase glutamate (show GRIN1 Antibodies) uptake during hypoxia, and these functions may underlie its neuroprotective effects.
Glutamine synthetase deficiency in murine astrocytes results in neonatal death.
The protein encoded by this gene belongs to the glutamine synthetase family. It catalyzes the synthesis of glutamine from glutamate and ammonia. Glutamine is a main source of energy and is involved in cell proliferation, inhibition of apoptosis, and cell signaling. This gene is expressed during early fetal stages, and plays an important role in controlling body pH by removing ammonia from circulation. Mutations in this gene are associated with congenital glutamine deficiency. Several alternatively spliced transcript variants have been found for this gene.
, glutamate-ammonia ligase (glutamine synthase)
, glutamate-ammonia ligase (glutamine synthetase)
, glutamine synthetase GlnA
, glutamine synthetase (glnA)
, cell proliferation-inducing protein 59
, glutamate decarboxylase
, glutamate--ammonia ligase
, glutamine synthase
, proliferation-inducing protein 43
, Glutamine synthetase (glutamate-ammonia ligase)
, glutamine synthetase 1